Wikström S, Parkkulainen K V, Louhimo I
J Pediatr Surg. 1982 Jun;17(3):269-72. doi: 10.1016/s0022-3468(82)80010-9.
A series of six patients with bilateral Wilms' tumor (nephroblastoma) is presented. Multimodal therapy yielded a survival rate of 83% at 2 yr of follow-up. However, at the end of a later follow-up period only two patients (33%) were alive. of the 4 patients who died. Only 1 died of Wilms' tumor. One died of complications of aggressive chemotherapy and two patients died after 12 and 16 yr following treatment of secondary malignant tumors arising in the irradiated region. Patients with bilateral tumor should be followed at regular intervals for the duration of life for the occurrence of secondary malignant tumors.
本文报告了6例双侧肾母细胞瘤患者。多模式治疗在2年随访期的生存率为83%。然而,在随后更长的随访期结束时,只有2例患者(33%)存活。在4例死亡患者中,只有1例死于肾母细胞瘤。1例死于强化化疗的并发症,2例在接受放疗区域出现继发性恶性肿瘤治疗后12年和16年死亡。双侧肿瘤患者应终身定期随访,以观察继发性恶性肿瘤的发生情况。